首页> 美国卫生研究院文献>other >Multiplexed Colorimetric Detection of Kaposi’s Sarcoma Associated Herpesvirus and Bartonella DNA using Gold and Silver Nanoparticles
【2h】

Multiplexed Colorimetric Detection of Kaposi’s Sarcoma Associated Herpesvirus and Bartonella DNA using Gold and Silver Nanoparticles

机译:卡波济氏肉瘤相关疱疹病毒和DNa巴尔通体采用黄金的复用比色检测和银纳米粒子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kaposi’s sarcoma (KS) is an infectious cancer occurring most commonly in human immunodeficiency virus (HIV) positive patients and in endemic regions, such as Sub-Saharan Africa, where KS is among the top four most prevalent cancers. The cause of KS is the Kaposi’s sarcoma-associated herpesvirus (KSHV, also called HHV-8), an oncogenic herpesvirus that while routinely diagnosed in developed nations, provides challenges to developing world medical providers and point-of-care detection. A major challenge in the diagnosis of KS is the existence of a number of other diseases with similar clinical presentation and histopathological features, requiring the detection of KSHV in a biopsy sample. In this work we develop an answer to this challenge by creating a multiplexed one-pot detection system for KSHV DNA and DNA from a frequently confounding disease, bacillary angiomatosis. Gold and silver nanoparticle aggregation reactions are tuned for each target and a multi-color change system is developed capable of detecting both targets down to levels between 1 nM and 2 nM. The system developed here could later be integrated with microfluidic sample processing to create a final device capable of solving the two major challenges in point-of-care KS detection.
机译:卡波西肉瘤(KS)是一种传染性癌症,最常见于人类免疫缺陷病毒(HIV)阳性患者和地方性地区,例如撒哈拉以南非洲,在那里,KS是最常见的四大癌症之一。 KS的病因是卡波西氏肉瘤相关的疱疹病毒(KSHV,也称为HHV-8),一种致癌性疱疹病毒,虽然在发达国家已被常规诊断,但对发展中国家的医疗服务提供者和现场即时检测提出了挑战。诊断KS的主要挑战是存在许多其他具有相似临床表现和组织病理学特征的疾病,需要在活检样本中检测KSHV。在这项工作中,我们通过为KSHV DNA和来自经常混淆的疾病,细菌性血管瘤病的DNA创建多路一锅检测系统,开发出应对这一挑战的方法。针对每个靶标调整金和银纳米粒子的聚集反应,并开发了一种多色变化系统,能够检测两个靶标,其浓度均降至1 nM至2 nM之间。此处开发的系统可以稍后与微流体样品处理集成,以创建一种能够解决即时医疗服务KS检测中的两个主要挑战的最终设备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号